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We have reviewed theevidence in favorofa prostaglandin mediatorofthethermal responses in
fever and found that PGE injected into the hypothalamus does not always cause fever, that
cerebrospinal fluid concentrations ofPGE are not reliable reflections ofhypothalamic events, and
that antipyretic drugs may act in ways other than inhibiting PGE synthesis. Fever is not blocked
by prostaglandin antagonists, nor by ablation of PGE-sensitive areas of the brain. There is poor
correlation between the effects of pyrogens and of PGE on cerebral neurons. There is evidence
that at leastone prostanoid otherthan prostaglandin is a mediator offever, but theprostanoid has
not been identified yet. Weconclude that PGE maycontribute tothe neural responses in fever but
is not essential.
Whatever the origin of the fever, many of the physiological and biochemical events
which constitute the host response are mediated by interleukin-1 (IL-1) [1]. The
thermal consequences of fever result from an interaction between IL-1 and cerebral
neurons [2]. Circulating IL-I does not appear to enter brain tissue, so there has been a
search for mediators of the interaction. The initial step of the interaction involves
protein synthesis in the brain [3,4]. Our paper concerns the hypothesis that there is a
second step in the interaction, one which involves prostanoid synthesis.
It is fifteen years since Milton and Wendlandt [5] injected prostaglandin E (PGE)
intothecerebral ventricles ofcats and observed prompt and potent hyperthermia. Soon
afterward, Feldberg and Gupta [6] demonstrated increased concentration of PGE in
ventricular cerebrospinal fluid (CSF) following injections of pyrogens in cats, and
Philipp-Dormston [7] reported increased PGE concentrations in the lumbar CSF of
febrile patients. At the same time, Vane [8] discovered that aspirin and other
well-known antipyretic drugs share the property ofinhibiting prostaglandin synthesis.
Since then further evidence, along similar lines, has accrued relating to PGE
involvement during fever, and this evidence has been reviewed recently by Milton [9].
Elsewhere in this symposium the case will be argued that the accumulation of
circumstantial evidence justifies the proposition that PGE is an essential neural
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mediator of the febrile response. We take a different view; namely, that the case for
PGE is unproven. Though we concede that PGE is released in the brain during fever
and is highly pyrogenic, we and others have evidence that PGE release is not an
essential stage of the development of fever. This evidence has been reviewed briefly
before [10,11,12]. Here we consolidate and extend our case.
IS THE EVIDENCE IN FAVOR OF PROSTAGLANDIN
INVOLVEMENT VALID?
Does PGE Injection Always Cause Hyperthermia?
In many animal species, microinjection of PGE into the anterior hypothalamic/
pre-optic (AH/PO) area, or into the cerebral ventricles, causes a prompt rise of body
temperature, which is sustained for several hours [9]. PGE, and PGE2 have similar,
but not necessarily equipotent, effects. The thermoregulatory mechanisms by which
the rise in temperature is achieved are similar to those evident following intravenous
injections ofpyrogens [13]. If, however, brain PGE synthesis is an essential component
of the elevation of body temperature in fever, then PGE injection should cause the
appropriate rise in body temperature, in the same species and circumstances in which
pyrogensdoso. Pittman, Veale, and Cooper [14,15] showed that lambs and sheepoften
did not respond to intrahypothalamic PGE injection, at a time when fever developed
following intravenous injection of bacterial pyrogen. Other workers indeed demon-
strated both elevated body temperature and appropriate thermoregulatory reactions in
sheep in response to intracerebroventricular (ICV), rather than intrahypothalamic,
PGE [16,17]. ICV infusion ofPGE in adult goats, on the other hand, had no effect on
body temperature [18].
Thus, although injection ofPGE in or near the AH/PO area of many species causes
a fever-like change in body temperature, it does not do so in all circumstances.
What Do Changes in CSFPGE Concentration Mean?
One of the traditional arguments supporting a role for PGE as the neural mediator
ofthe febrile response was the increase in the CSFconcentration ofPGEwhich follows
injection of pyrogen [6,19] and the fact that this increase is abolished by antipyretic
drugs [20]. The situation changed when sodium salicylate was shown to abolish the
increase in CSF PGE concentrations which otherwise occurred following intravenous
injection of endogenous pyrogen' (EP) in rabbits, but did not affect the fever [21].
Later, indomethacin was shown to effect a similar dissociation [22].
The experiments demonstrating dissociation between fever and PGE concentration
prompted a re-evaluation of the meaning of CSF PGE concentrations. Bernheim,
Gilbert, and Stitt [23] criticized the methodology of Cranston et al. [21], who used
CSF tapped from the cisterna magna, which is relatively distant from the AH/PO
area. The lumbar spinal column is even more remote, of course, so that, according to
that argument, one certainly should not accept that the increase in PGE concentration
which occurs in human lumbar CSFduring fever [7,24] is evidence supporting PGE as
the neural mediator offever.
Bernheim and his colleagues [23] analyzed CSF from the third ventricle of febrile
rabbits; the concentration of PGE showed a significant positive correlation with body
l Pure endogenous pyrogen (EP) subsequently has been shown to be identical to IL-1; we shall use
"endogenous pyrogen" to denote the crude preparation of IL-I we and others used at the time.
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temperature elevation. Using a similar procedure, Crawford and colleagues [25] also
collected rabbit third ventricular PGE during fever, and their data can be analyzed in
the same way: thesedata exhibit no significant correlation between PGE concentration
and body temperature.
In view of the contradictory results, it is worth discussing what CSF PGE
concentration represents. IfPGE appears in theAH/PO area as a consequenceofIL-I
action, it must be synthesized locally or enter from the blood. It is unlikely to enter
from the CSF. Rapid washout of the ventricular system of rabbits did not affect EP
fever [26]. Also, filling the ventricular space with inert oil exaggerated, rather than
diminished, thefebrile responseto EP [27]. Thusany PGE in theCSFmust been route
from the brain tissue. Veale and Cooper [28] demonstrated that PGE from the
hypothalamus indeed enters the CSF by perfusing the hypothalamus with radioactive
PGE and sampling CSF washed from lateral ventricle to cisterna magna.
The hypothalamus is not the only site of origin of PGE entering CSF during fever:
the PGE probably originates from widespread areas of the brain [29]. Thus CSF
concentrations ofPGE do not necessarily reflect recent events in the AH/PO area.
There are other problems that confound the interpretation ofCSF PGE concentra-
tions. During fever, the CSF contains leucocytes which elaborate prostaglandins and
may continue to do so after the sample is taken, and it contains protein which binds
prostaglandin [30]. Coceani and his colleagues [30] believe that many measurements
ofCSF prostaglandin concentration, and especially thoseofBernheim et al. [23], have
been erroneously high.
Thus, current measurements of CSF PGE concentration may be wrong, for
technical reasons and, even ifcorrectly measured, may not reflect what is happening in
the AH/PO area. We doubt whether any ofthe current studies ofCSF prostaglandin
concentration are valid evidence either for or against the involvement of PGE as the
neural mediator offever.
Do Intracerebral Injections ofRealistic Doses ofPGE Cause Fever?
In many of the investigations of the possible hyperthermic activity of PGE,
microinjections have been made into the lateral or third ventricles, in the expectation
that the prostaglandin will reach the AH/PO area. For the reasons given above,
administering PGE from ventricle to hypothalamus is against the normal diffusion
direction. Moreover, prostaglandin does not diffuse easily through brain tissue:
microinjections into brain tissue at sites a few millimeters away from the AH/PO
region, even in sensitive species, have no effect on body temperature [31]. Conse-
quently, ICV injections ofPGE have to be made at relatively high doses, and whether
the effects they cause are physiological may be questioned.
Even when injections are made directly into the hypothalamus, the doses necessary
to produce significant hyperthermia seem high to us. According to Stitt [13], a dose of
20 ng or more ofPGE, is necessary in rabbits. This dose will be distributed over a few
cubic millimeters of tissue, so the peak local concentration may exceed 1,000 ng/ml.
The CSF concentration ofPGE in afebrile rabbits is less than 0.5 ng/ml [30]. During
fever, CSFPGEconcentration mayincreasetenfold, according to Bernheimetal. [23],
though other authors report only a doubling or tripling of concentration [19,20,30].
The tissue concentrations necessary to produce a CSF concentration of a few ng/ml
will be somewhat higher but are likely to be orders of magnitude lower than 1,000
ng/ml.
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Is Inhibition ofProstaglandin Synthesis the Mechanism ofAction
ofAntipyretic Drugs?
Many antipyretic drugs are able to inhibit prostaglandin synthesis in brain tissue
[32,33]. They do so by inhibiting the activity of cyclooxygenase enzymes (Fig. 1).
However, the drugs have other actions too [34], and the possibility that these other
actions may account for the antipyretic properties has not been investigated extensive-
ly. The potent antipyretic indomethacin, for example, inhibits cyclic AMP-dependent
protein kinase at concentrations orders of magnitude lower than those at which it
inhibits cyclooxygenase [35]. Clark and Cumby [36] indeed concluded that neither
indomethacin nor paracetamol exert their antipyretic action by inhibiting prostaglan-
din synthesis.
Apart from those already mentioned [21,22] there areother reports dissociating the
inhibition of prostaglandin synthesis by aspirin-like drugs from antipyresis. Floctafe-
nine is reported to be as potent as indomethacin in inhibiting prostaglandin synthesis
but has far lower antipyretic action when injected directly into the cerebral ventricles
ofrabbits [37]. Abdel-Halim and co-workers [38] found that the common antipyretics
aspirin and paracetamol do not inhibit prostaglandin synthesis in rat brain homogen-
ates at concentrations at which they are certainly antipyretic in vivo.
Until possible mechanisms ofaction other than inhibition ofprostaglandin synthesis
have been eliminated properly, it is unjustified to claim that the antipyretic action of
aspirin-like drugs is proof that prostaglandin is the neural mediator of the febrile
response. Even ifcyclooxygenase inhibition is shown tobethe relevant mechanism, any
of the multiple products of cyclooxygenase activity (Fig.1) may be a mediator of
fever.
THE EVIDENCE AGAINST AN ESSENTIAL ROLE FOR PGE
Prostaglandin Antagonists
Perhaps the strongest evidence that any brain prostaglandin synthesized during
pyrogen fever does not play an essential role in the genesis of the fever derives from
experiments using prostaglandin antagonists. Sanner [39] was the first to notice that
the PGE antagonist SC 19220, injected intraperitoneally in rabbits, did not diminish
fever. Systemic injection of the antagonist produces severe side effects, making
interpretation of the results difficult [40]. However, ICV injections of two PGE
antagonists SC 19220 and HR 546 have less severe side effects, and such injections
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abolished the hyperthermia which followed ICV injection ofPGE2 but had no effect on
the fever which followed an equipotent dose ofEP [41].
Milton [9] criticized the experiments of Cranston et al. [41] on the grounds of the
high doses of antagonists used and recommended that any conclusion be held in
abeyance until a more potent, more specific, centrally active prostaglandin antagonist
became available. In the ten years since the work was done, no better antagonist has
become available, as far as we are aware.
Hypothalamic Ablation
Further evidence inconsistent with an essential role for PGE has been provided by
Veale and Cooper [42], who observed the consequence of bilateral ablation of the
AH/PO area. In some rabbits, following the ablation, PGE, had no effect on body
temperature, whether administered into the AH/PO region or ICV. EP, however,
injected either ICV or intravenously produced a fever ofnormal height, though slower
onset. The EP must have acted at a site other than the AH/PO to produce the fever,
perhaps the midbrain siteofRosendorffand Mooney [43]. Unless this site is peculiarly
inaccessible to ICV PGE, it appears not to be sensitive to PGE, and the thermal
responses generated at it consequently are not dependent on PGE.
Neuronal Responses to Pyrogens andProstaglandins
If PGE is the neural mediator of fever, then one would expect that it would affect
neurons in the AH/PO area of the brain in a way consistent with the way in which
pyrogens affect these neurons. The temperature-sensitive neurons in the hypothalamus
behave in a rather consistent wayfollowing intravascularinjectionofbacterial pyrogen
or EP. Eisenman [44] recently has consolidated the results of various authors: 95
percent of all warm-sensitive neurons had been inhibited by pyrogens, and 95 percent
of all cold-sensitive neurons facilitated. Thermosensitive neurons in the brain stem
[45,46] show similar responses to intravenous pyrogens, and the same pattern of
responses, with more rapid onset, is evident when EP is microinjected directly into the
AH/PO area [47] or the brain stem [48].
Reports on the action ofPGE administered locally on temperature-sensitive neurons
are not nearly so consistent [44]. Some authors report a pattern of responses very
similar to the pyrogen pattern [49], but others [50] found no association between
temperature and PGE sensitivity. In his consolidation ofthe results ofvarious authors,
Eisenman [44] found that three-quarters of all warm-sensitive neurons investigated
had not been affected by PGE, nor had almost halfthecold-sensitive neurons. Thus the
action ofPGE on temperature-sensitive neurons is not at all like the action ofpyrogens
on the neurons, so it is difficult to accept that PGE mediates the action ofthe pyrogens
on the neurons.
It is possible that the neurons responsible for the upward shift ofbody temperature
regulation during fever are neurons insensitive to changes in their own temperature
[441. If this were the case, one would expect pyrogens and PGE to have a consistent
effect on thethermally insensitive neuronsoftheAH/PO area. It turns out that almost
none ofthe insensitive neurons are affected by either pyrogens or PGE [44].
IS THERE AN ESSENTIAL PROSTANOID MEDIATOR
OF THE FEBRILE RESPONSE?
The appearance of prostaglandin implies that phospholipase A2 is activated during
fever, and consequently all of the associated prostanoids will be present too, provided
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that subsequent enzymes in the pathways are available (Fig. 1). Cranston et al. [51]
investigated whether any of the prostanoids or leukotrienes are essential mediators of
fever by using drugs which inhibit the activity of phospholipase A2, and which
therefore block the biosynthetic pathway at its origin (Fig. 2). Two disparate drugs,
mepacrine and parabromophenacylbromide, injected ICV rather than given orally
[52], abolished EP fever forat least an hour after injection and attenuated it thereafter
[51]. They concluded that at least one of the metabolites is an essential mediator, at
least in the initial stages offever.
The metabolite is not arachidonic acid itself. ICV injection of arachidonic acid
elevates body temperature, but the hyperthermia is abolished, at least initially, by
cyclooxygenase inhibitors [36,53,54], so the active metabolite is downstream of
arachidonic acid. It is not a product of lipoxygenase activity [55], but may be a
non-prostaglandin product of cyclooxygenase activity (Fig. 1). Laburn and her
colleagues injected arachidonic acid together with the prostaglandin antagonists SC
19220 and HR 546 ICV into rabbits [54]. Although the antagonists abolished the
hyperthermic effects of PGE administered by the same route, they inhibited only
transiently the hyperthermia of arachidonic acid (Fig. 3), confirming again that
prostaglandin is notan essential intermediate in theprocess. However, wecanconclude
that either the endoperoxides, or the thromboxanes, or prostacyclin, or possibly other
metabolites not shown in Fig. 1, are involved in the febrile process.
Investigation of the action of the endoperoxides is difficult, because they are
unstable and short-lived. Stable analogs of the endoperoxides are available, however,
and Harrisberg et al. [56] haveshown that ICV injections ofone suchanalog in rabbits
resulted in dose-dependent hyperthermia. Unfortunately, in the hands of the others,
endoperoxide analogs have proven hyperthermic, hypothermic, inactive, or toxic
[57,58] so the evidence for or against their involvement in fever remains equivocal.
Another candidate mediator is prostacyclin. ICV injections of prostacyclin in cats
and rabbits produce long-lasting elevations ofbody temperature, at doses higher than
those necessary in the caseofPGE [58,59]. However, ICV prostacyclin is hypothermic
in guinea pigs [60], sothat, even ifit is involved in thefebrile process in some species, it
cannot be an essential mediator offever.
The final candidate prostanoids in the cyclooxygenase pathways are the thrombox-
anes. Again, they are unstable and difficult to investigate. Coceani and his colleagues
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have detected elevated levels ofthromboxane B2, the stable metabolite ofthromboxane
synthesis from arachidonic acid, in the CSF of cats in the rising phase of fever [30].
They also found that imidazole, which inhibits synthesis of thromboxanes from
endoperoxides, suppressed both the fever and the thromboxane B2 synthesis. Milton
and his colleagues [58], on the other hand, were unable to detect any effect of
imidazole on the hyperthermia which followed arachidonic acid injection in rabbits.
Too little work has been done on thromboxanes to allow any firm conclusions about
their involvement in fever, but it remains possible that they contribute to the process in
some way.
In summary, therefore, we believe that synthesis of one or more ofthe prostanoids is
an essential stage of at least the initial phases of fever, and more than one prostanoid
may contribute to the overall process. We do not know what the essential prostanoid is
yet, and it may not be the same one in different species. We cannot exclude the
possibility of a non-prostanoid mediator, nor of a direct action ofIL- I on neurons, after
the first few hours offever.
WHAT IS THE ROLE OF PGE?
Our contention is the PGE synthesis is not essential in fever; we do not deny that
PGE synthesis may contribute to the thermal component of fever. We conceive of at
least two roles that PGE may play.
The first role that could be assigned to PGE is mediation of the very early thermal
events in fever. When arachidonic acid was injected into rabbits, together with
prostaglandin antagonists, fever indeed was suppressed for about 30 minutes or so
following the injection [54]. The breakdown of arachidonic acid may produce at least
two pyrogenic derivatives, the faster-acting ofwhich is PGE. That PGE is responsible
for the initial stages offever is supported by the work ofSzekely [61,62], who believes
that PGE cannot account for all the thermal responses to endotoxin but may well
account for the first phase. Further support comes from Skarnes and his colleagues
[63], who showed that PGE was present in thejugular venous plasma ofsheep only in
the first 1'/2 hours of an endotoxin fever which lasted at least six hours, and peaked at
four hours (Fig. 4).
The second role of PGE derives from a consideration of the role PGE plays in an
entirely different physiological mechanism, nociception. PGE is released in peripheral
tissues during inflammation or trauma and contributes to the associated hyperalgesia.
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It does so, not by exciting the neuronal receptors directly, but by sensitizing them to
other forms of noxious stimulation [64]. The cyclooxygenase inhibitors, which are
analgesics as well as antipyretics, function by preventing this sensitization. By analogy,
PGE may sensitize the neurons involved in fever to IL-1, endogenous neurotransmit-
ters, or some other intermediate as yet unidentified [51].
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